| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $97,500 ) |
| | 2025 | 2025 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 428 OAKMEAD PKWY | SUNNYVALE | CA | 94085-4708 | SANTA CLARA | USA | R03AI185412 | Metabolomics and transcriptomics analyses of cell-specific regulation of fatty acid synthesis and metabolic reprogramming in skin inflammation | 000 | 2 | NIH | 4/25/2025 | $97,500 |
| | 2025 | 2023 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 428 OAKMEAD PKWY | SUNNYVALE | CA | 94085 | SANTA CLARA | USA | R03AI166365 | Function- and interaction-based discovery of negative allosteric modulators of the A2A Receptor | 000 | 2 | NIH | 11/26/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $97,500 ) |
| | 2024 | 2024 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 428 OAKMEAD PKWY | SUNNYVALE | CA | 94085-4708 | SANTA CLARA | USA | R03AI185412 | Metabolomics and transcriptomics analyses of cell-specific regulation of fatty acid synthesis and metabolic reprogramming in skin inflammation | 001 | 1 | NIH | 9/11/2024 | $9,750 |
| | 2024 | 2024 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 428 OAKMEAD PKWY | SUNNYVALE | CA | 94085-4708 | SANTA CLARA | USA | R03AI185412 | Metabolomics and transcriptomics analyses of cell-specific regulation of fatty acid synthesis and metabolic reprogramming in skin inflammation | 000 | 1 | NIH | 6/17/2024 | $87,750 |
| | 2024 | 2021 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 428 OAKMEAD PKWY | SUNNYVALE | CA | 94085-4708 | SANTA CLARA | USA | R21AI149108 | Role of miRNA for the regulation of macrophage metabolism and phenotype determination in inflammatory disease | 000 | 2 | NIH | 5/6/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $97,500 ) |
| | 2023 | 2023 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 428 OAKMEAD PKWY | SUNNYVALE | CA | 94085-4708 | SANTA CLARA | USA | R03AI166365 | Function- and interaction-based discovery of negative allosteric modulators of the A2A Receptor | 000 | 2 | NIH | 4/20/2023 | $97,500 |
|
| Issue Date FY: 2022 ( Subtotal = $97,500 ) |
| | 2022 | 2022 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 428 OAKMEAD PKWY | SUNNYVALE | CA | 94085-4708 | SANTA CLARA | USA | R03AI166365 | Function- and interaction-based discovery of negative allosteric modulators of the A2A Receptor | 000 | 1 | NIH | 5/23/2022 | $97,500 |
|
| Issue Date FY: 2021 ( Subtotal = $292,500 ) |
| | 2021 | 2021 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 428 OAKMEAD PKWY | SUNNYVALE | CA | 94085-4708 | SANTA CLARA | USA | R21AI149108 | Role of miRNA for the regulation of macrophage metabolism and phenotype determination in inflammatory disease | 001 | 2 | NIH | 6/17/2021 | $292,500 |
| | 2021 | 2020 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 428 OAKMEAD PKWY | SUNNYVALE | CA | 94085-4708 | SANTA CLARA | USA | R21AI149108 | Role of miRNA for the regulation of macrophage metabolism and phenotype determination in inflammatory disease | 000 | 1 | NIH | 5/5/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $243,750 ) |
| | 2020 | 2020 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 428 OAKMEAD PKWY | SUNNYVALE | CA | 94085-4708 | SANTA CLARA | USA | R21AI149108 | Role of miRNA for the regulation of macrophage metabolism and phenotype determination in inflammatory disease | 000 | 1 | NIH | 6/19/2020 | $243,750 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2019 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 428 OAKMEAD PKWY | SUNNYVALE | CA | 94085-4708 | SANTA CLARA | USA | R21GM126264 | A NOVEL CHEMOPROTEOMIC TECHNOLOGY TO REVEAL GLOBAL SMALL MOLECULE-PROTEOME-WIDE INTERACTIONS IN LIVE CELLS. | 001 | 1 | NIH | 6/12/2019 | -$292,500 |
| | 2019 | 2019 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 428 OAKMEAD PKWY | SUNNYVALE | CA | 94085-4708 | SANTA CLARA | USA | R21GM126264 | A NOVEL CHEMOPROTEOMIC TECHNOLOGY TO REVEAL GLOBAL SMALL MOLECULE-PROTEOME-WIDE INTERACTIONS IN LIVE CELLS. | 000 | 1 | NIH | 1/31/2019 | $292,500 |
|
| Issue Date FY: 2015 ( Subtotal = $243,750 ) |
| | 2015 | 2015 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 525 DEL REY AVENUE, SUITE B | SUNNYVALE | CA | 94086 | SANTA CLARA | USA | R21AI105518 | Positive allosteric modulation of the A2aR for treatment of acute inflammation | 000 | 2 | NIH | 11/5/2014 | $243,750 |
|
| Issue Date FY: 2014 ( Subtotal = $292,500 ) |
| | 2014 | 2014 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 525 DEL REY AVENUE, SUITE B | SUNNYVALE | CA | 94086 | SANTA CLARA | USA | R21AI105518 | Positive allosteric modulation of the A2aR for treatment of acute inflammation | 001 | 1 | NIH | 6/11/2014 | $29,250 |
| | 2014 | 2014 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 525 DEL REY AVENUE, SUITE B | SUNNYVALE | CA | 94086 | SANTA CLARA | USA | R21AI105518 | Positive allosteric modulation of the A2aR for treatment of acute inflammation | 000 | 1 | NIH | 11/29/2013 | $263,250 |
|
| Issue Date FY: 2009 ( Subtotal = $0 ) |
| | 2009 | 2008 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 525 DEL REY AVENUE, SUITE B | SUNNYVALE | CA | 94086 | SANTA CLARA | USA | R01DA014026 | DISCOVERY OF SMALL-MOLECULE ORPHANIN FQ RECEPTOR LIGANDS | 000 | 6 | NIH | 1/28/2009 | $0 |
| | 2009 | 2008 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 525 DEL REY AVENUE, SUITE B | SUNNYVALE | CA | 94086 | SANTA CLARA | USA | R01DA014026 | DISCOVERY OF SMALL-MOLECULE ORPHANIN FQ RECEPTOR LIGANDS | 001 | 6 | NIH | 9/14/2009 | $0 |
|
| Issue Date FY: 2008 ( Subtotal = $198,940 ) |
| | 2008 | 2008 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 525 DEL REY AVENUE, SUITE B | SUNNYVALE | CA | 94086 | SANTA CLARA | USA | R01DA014026 | DISCOVERY OF SMALL-MOLECULE ORPHANIN FQ RECEPTOR LIGANDS | 000 | 6 | NIH | 8/28/2008 | $198,940 |
|
| Issue Date FY: 2000 ( Subtotal = $76,185 ) |
| | 2000 | 2000 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 525 DEL REY AVENUE, SUITE B | SUNNYVALE | CA | 94086 | SANTA CLARA | USA | P01CA051993 | SELECTIVE RETINOIDS FOR BREAST CANCER THERAPY | 001 | 8 | NIH | 12/13/1999 | $76,185 |
|
| Issue Date FY: 1999 ( Subtotal = $1,281,100 ) |
| | 1999 | 1999 | MOLECULAR MEDICINE RESEARCH INSTITUTE | 525 DEL REY AVENUE, SUITE B | SUNNYVALE | CA | 94086 | SANTA CLARA | USA | P01CA051993 | SELECTIVE RETINOIDS FOR BREAST CANCER THERAPY | 000 | 8 | NIH | 5/28/1999 | $1,281,100 |
|
|
